Publications by authors named "Silvan Vesenbeckh"

Claim this Profile
D
Diagnosis of Peripheral Pulmonary Lesions Using Forceps and 1.1- or 1.7-mm Cryoprobes: A Randomised Trial.
Carolin Steinack, Jan Hendrik Rüschoff, Maurice Roeder, Silvan Manuel Vesenbeckh, Silvia Ulrich

Respiration· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronavirus infection and chronic lung allograft dysfunction: a retrospective cohort study.
Lydia Canham, Carolin Steinack, René Hage, Maurice Roeder, Silvia Ulrich, Silvan Vesenbeckh

Swiss Med Wkly· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transbronchial cryobiopsy alone versus combined with traditional forceps biopsy for acute cellular rejection in lung transplant recipients. A diagnostic randomized trial.
Carolin Steinack, Maurice Roeder, Silvan Vesenbeckh, Martina Haberecker, Jan H Rüschoff

JHLT Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound-guided transbronchial cryobiopsy of mediastinal and hilar lesions: a multicenter pragmatic cohort study with real-world evidence.
Melanie Scarlett Mangold, Daniel P Franzen, Jürgen Hetzel, Tsogyal D Latshang, Maurice Roeder, Silvan M Vesenbeckh

BMJ Open Respir Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 in an immunocompromised host: convalescent plasma therapy and viral evolution elucidated by whole genome sequencing.
Helena Seth-Smith, Silvan Vesenbeckh, Adrian Egli, Sebastian Ott

BMJ Case Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Viral Infection and Bacterial Coinfection and Superinfection in Coronavirus Disease 2019 Patients Presenting to the Emergency Department Using the 29-mRNA Host Response Classifier IMX-BVN-3: A Multicenter Study.
Wolfgang Bauer, Sven Gläser, Dorina Thiemig, Katrin Wanner, Alexander Peric, Silvan Vesenbeckh

Open Forum Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline as a potential agent in the treatment of infections.
Silvan Vesenbeckh, Nicolas Schönfeld, Andreas Roth, Gudrun Bettermann, David Krieger

Eur Respir J· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline as a potential agent in the treatment of and infections.
Silvan Vesenbeckh, Nicolas Schönfeld, David Krieger, Gudrun Bettermann, Torsten Thomas Bauer

Eur Respir J· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In reply.
Ralf Otto-Knapp, Silvan Vesenbeckh, Nicolas Schönfeld, Gudrun Bettermann, Andreas Roth

Int J Tuberc Lung Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is delamanid a potential agent in the treatment of diseases caused by Mycobacterium avium-intracellulare?
David Krieger, Nicolas Schönfeld, Silvan Vesenbeckh, Gudrun Bettermann, Torsten Thomas Bauer

Eur Respir J· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation.
Ralf Otto-Knapp, Silvan Vesenbeckh, Nicolas Schönfeld, Gudrun Bettermann, Andreas Roth

Int J Tuberc Lung Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outbreak of isoniazid-resistant tuberculosis in an immigrant community in Spain.
Cristina Hernán García, Lourdes Moreno Cea, Virginia Fernández Espinilla, Gema Ruiz Lopez Del Prado, Socorro Fernández Arribas, Silvan Vesenbeckh

Arch Bronconeumol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis.
Silvan Vesenbeckh, David Krieger, Gudrun Bettermann, Nicolas Schönfeld, Torsten Thomas Bauer

Tuberculosis (Edinb)· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mefloquine as a potential drug against multidrug-resistant tuberculosis.
David Krieger, Silvan Vesenbeckh, Nicolas Schönfeld, Gudrun Bettermann, Torsten Thomas Bauer

Eur Respir J· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates.
Nicolas Schönfeld, Thorsten Bergmann, Silvan Vesenbeckh, Harald Mauch, Gudrun Bettermann

Lung India· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of interferon gamma release assays in the diagnosis of active tuberculosis.
Silvan M Vesenbeckh, Nicolas Schönfeld, Harald Mauch, Thorsten Bergmann, Sonja Wagner

Tuberc Res Treat· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reassessment of the 2010-2011 Haiti cholera outbreak and rainfall-driven multiseason projections.
Andrea Rinaldo, Enrico Bertuzzo, Lorenzo Mari, Lorenzo Righetto, Melanie Blokesch, Silvan M Vesenbeckh

Proc Natl Acad Sci U S A· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elimination of cholera transmission.
Didier Bompangue, Guillaume Le Duc, Silvan Vesenbeckh, Nikki Blackwell

Lancet· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholera ante portas - The re-emergence of cholera in Kinshasa after a ten-year hiatus.
Didier Bompangue, Silvan Manuel Vesenbeckh, Patrick Giraudoux, Marcia Castro, Jean-Jacques Muyembe

PLoS Curr· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hantavirus outbreak, Germany, 2007.
Jörg Hofmann, Helga Meisel, Boris Klempa, Silvan M Vesenbeckh, Robert Beck

Emerg Infect Dis· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models.
Gustavo R Morel, Paula C Reggiani, Gloria M Console, Omar J Rimoldi, Silvan M Vesenbeckh

Curr Gene Ther· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice.
Rodolfo G Goya, Paula C Reggiani, Silvan M Vesenbeckh, Jean M Pléau, Yolanda E Sosa

Am J Physiol Endocrinol Metab· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphometric assessment of the impact of serum thymulin immunoneutralization on pituitary cell populations in peripubertal mice.
Gisela Camihort, Georgina Luna, Silvan Vesenbeckh, Celia Ferese, Mireille Dardenne

Cells Tissues Organs· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis